Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review.

The journal of venomous animals and toxins including tropical diseases

Buchaim DV, Cassaro CV, Shindo JVTC, Coletta BBD, Pomini KT, Rosso MPO, Campos LMG, Ferreira RS, Barraviera B, Buchaim RL.
PMID: 31839802
J Venom Anim Toxins Incl Trop Dis. 2019 Nov 11;25:e20190038. doi: 10.1590/1678-9199-JVATITD-2019-0038. eCollection 2019.

Fibrin biopolymers, previously referred as "fibrin glue" or "fibrin sealants", are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically,...

Cite
Buchaim DV, Cassaro CV, Shindo JVTC, et al. Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review. J Venom Anim Toxins Incl Trop Dis. 2019;25:e20190038doi: 10.1590/1678-9199-JVATITD-2019-0038.
Buchaim, D. V., Cassaro, C. V., Shindo, J. V. T. C., Coletta, B. B. D., Pomini, K. T., Rosso, M. P. O., Campos, L. M. G., Ferreira, R. S., Barraviera, B., & Buchaim, R. L. (2019). Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review. The journal of venomous animals and toxins including tropical diseases, 25e20190038. https://doi.org/10.1590/1678-9199-JVATITD-2019-0038
Buchaim, Daniela Vieira, et al. "Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review." The journal of venomous animals and toxins including tropical diseases vol. 25 (2019): e20190038. doi: https://doi.org/10.1590/1678-9199-JVATITD-2019-0038
Buchaim DV, Cassaro CV, Shindo JVTC, Coletta BBD, Pomini KT, Rosso MPO, Campos LMG, Ferreira RS, Barraviera B, Buchaim RL. Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review. J Venom Anim Toxins Incl Trop Dis. 2019 Nov 11;25:e20190038. doi: 10.1590/1678-9199-JVATITD-2019-0038. eCollection 2019. PMID: 31839802; PMCID: PMC6894437.
Copy Download .nbib Format: NLM
A clinical trial protocol to treat massive Africanized honeybee (.

The journal of venomous animals and toxins including tropical diseases

Barbosa AN, Boyer L, Chippaux JP, Medolago NB, Caramori CA, Paixão AG, Poli JPV, Mendes MB, Dos Santos LD, Ferreira RS, Barraviera B.
PMID: 28331487
J Venom Anim Toxins Incl Trop Dis. 2017 Mar 16;23:14. doi: 10.1186/s40409-017-0106-y. eCollection 2017.

BACKGROUND: Envenomation caused by multiple stings from Africanized honeybees METHODS: In order to evaluate the safety and neutralizing capacity of a new apilic antivenom, as well as to confirm its lowest effective dose, a clinical protocol was developed to...

Cite
Barbosa AN, Boyer L, Chippaux JP, et al. A clinical trial protocol to treat massive Africanized honeybee (. J Venom Anim Toxins Incl Trop Dis. 2017;23:14doi: 10.1186/s40409-017-0106-y.
Barbosa, A. N., Boyer, L., Chippaux, J. P., Medolago, N. B., Caramori, C. A., Paixão, A. G., Poli, J. P. V., Mendes, M. B., Dos Santos, L. D., Ferreira, R. S., & Barraviera, B. (2017). A clinical trial protocol to treat massive Africanized honeybee (. The journal of venomous animals and toxins including tropical diseases, 2314. https://doi.org/10.1186/s40409-017-0106-y
Barbosa, Alexandre Naime, et al. "A clinical trial protocol to treat massive Africanized honeybee (." The journal of venomous animals and toxins including tropical diseases vol. 23 (2017): 14. doi: https://doi.org/10.1186/s40409-017-0106-y
Barbosa AN, Boyer L, Chippaux JP, Medolago NB, Caramori CA, Paixão AG, Poli JPV, Mendes MB, Dos Santos LD, Ferreira RS, Barraviera B. A clinical trial protocol to treat massive Africanized honeybee (. J Venom Anim Toxins Incl Trop Dis. 2017 Mar 16;23:14. doi: 10.1186/s40409-017-0106-y. eCollection 2017. PMID: 28331487; PMCID: PMC5356296.
Copy Download .nbib Format: NLM
Synaptic plasticity and sensory-motor improvement following fibrin sealant dorsal root reimplantation and mononuclear cell therapy.

Frontiers in neuroanatomy

Benitez SU, Barbizan R, Spejo AB, Ferreira RS, Barraviera B, Góes AM, de Oliveira AL.
PMID: 25249946
Front Neuroanat. 2014 Sep 09;8:96. doi: 10.3389/fnana.2014.00096. eCollection 2014.

Root lesions may affect both dorsal and ventral roots. However, due to the possibility of generating further inflammation and neuropathic pain, surgical procedures do not prioritize the repair of the afferent component. The loss of such sensorial input directly...

Cite
Benitez SU, Barbizan R, Spejo AB, et al. Synaptic plasticity and sensory-motor improvement following fibrin sealant dorsal root reimplantation and mononuclear cell therapy. Front Neuroanat. 2014;8:96doi: 10.3389/fnana.2014.00096.
Benitez, S. U., Barbizan, R., Spejo, A. B., Ferreira, R. S., Barraviera, B., Góes, A. M., & de Oliveira, A. L. (2014). Synaptic plasticity and sensory-motor improvement following fibrin sealant dorsal root reimplantation and mononuclear cell therapy. Frontiers in neuroanatomy, 896. https://doi.org/10.3389/fnana.2014.00096
Benitez, Suzana U, et al. "Synaptic plasticity and sensory-motor improvement following fibrin sealant dorsal root reimplantation and mononuclear cell therapy." Frontiers in neuroanatomy vol. 8 (2014): 96. doi: https://doi.org/10.3389/fnana.2014.00096
Benitez SU, Barbizan R, Spejo AB, Ferreira RS, Barraviera B, Góes AM, de Oliveira AL. Synaptic plasticity and sensory-motor improvement following fibrin sealant dorsal root reimplantation and mononuclear cell therapy. Front Neuroanat. 2014 Sep 09;8:96. doi: 10.3389/fnana.2014.00096. eCollection 2014. PMID: 25249946; PMCID: PMC4158877.
Copy Download .nbib Format: NLM
Treatment of partial injury of the calcaneus tendon with heterologous fibrin biopolymer and/or photobiomodulation in rats.

Lasers in medical science

de Freitas Dutra Júnior E, Hidd SMCM, Amaral MM, Filho ALMM, Assis L, Ferreira RS, Barraviera B, Martignago CCS, Figueredo-Silva J, de Oliveira RA, Tim CR.
PMID: 34041619
Lasers Med Sci. 2021 May 26; doi: 10.1007/s10103-021-03341-x. Epub 2021 May 26.

The present study aimed to evaluate the new heterologous fibrin biopolymer associated, or not, with photobiomodulation therapy for application in tendon injuries, considered a serious and common orthopedic problem. Thus, 84 Rattus norvegicus had partial transection of the calcaneus...

Cite
de Freitas Dutra Júnior E, Hidd SMCM, Amaral MM, et al. Treatment of partial injury of the calcaneus tendon with heterologous fibrin biopolymer and/or photobiomodulation in rats. Lasers Med Sci. 2021;doi: 10.1007/s10103-021-03341-x.
de Freitas Dutra Júnior, E., Hidd, S. M. C. M., Amaral, M. M., Filho, A. L. M. M., Assis, L., Ferreira, R. S., Barraviera, B., Martignago, C. C. S., Figueredo-Silva, J., de Oliveira, R. A., & Tim, C. R. (2021). Treatment of partial injury of the calcaneus tendon with heterologous fibrin biopolymer and/or photobiomodulation in rats. Lasers in medical science, . https://doi.org/10.1007/s10103-021-03341-x
de Freitas Dutra Júnior, Enéas, et al. "Treatment of partial injury of the calcaneus tendon with heterologous fibrin biopolymer and/or photobiomodulation in rats." Lasers in medical science vol. (2021). doi: https://doi.org/10.1007/s10103-021-03341-x
de Freitas Dutra Júnior E, Hidd SMCM, Amaral MM, Filho ALMM, Assis L, Ferreira RS, Barraviera B, Martignago CCS, Figueredo-Silva J, de Oliveira RA, Tim CR. Treatment of partial injury of the calcaneus tendon with heterologous fibrin biopolymer and/or photobiomodulation in rats. Lasers Med Sci. 2021 May 26; doi: 10.1007/s10103-021-03341-x. Epub 2021 May 26. PMID: 34041619.
Copy Download .nbib Format: NLM
Good management practices of venomous snakes in captivity to produce biological venom-based medicines: achieving replicability and contributing to pharmaceutical industry.

Journal of toxicology and environmental health. Part B, Critical reviews

Santos L, Oliveira C, Vasconcelos BM, Vilela D, Melo L, Ambrósio L, da Silva A, Murback L, Kurissio J, Cavalcante J, Cassaro CV, Barros L, Barraviera B, Ferreira RS.
PMID: 33308037
J Toxicol Environ Health B Crit Rev. 2021 Jan 02;24(1):30-50. doi: 10.1080/10937404.2020.1855279. Epub 2020 Dec 14.

One of the factors responsible for lack of reproducible findings may be attributed to the raw material used. To date, there are no apparent studies examining reproducibility using venoms for the development of new toxin-based drugs with respect to...

Cite
Santos L, Oliveira C, Vasconcelos BM, et al. Good management practices of venomous snakes in captivity to produce biological venom-based medicines: achieving replicability and contributing to pharmaceutical industry. J Toxicol Environ Health B Crit Rev. 2020;24(1):30-50doi: 10.1080/10937404.2020.1855279.
Santos, L., Oliveira, C., Vasconcelos, B. M., Vilela, D., Melo, L., Ambrósio, L., da Silva, A., Murback, L., Kurissio, J., Cavalcante, J., Cassaro, C. V., Barros, L., Barraviera, B., & Ferreira, R. S. (2021). Good management practices of venomous snakes in captivity to produce biological venom-based medicines: achieving replicability and contributing to pharmaceutical industry. Journal of toxicology and environmental health. Part B, Critical reviews, 24(1), 30-50. https://doi.org/10.1080/10937404.2020.1855279
Santos, Lucilene, et al. "Good management practices of venomous snakes in captivity to produce biological venom-based medicines: achieving replicability and contributing to pharmaceutical industry." Journal of toxicology and environmental health. Part B, Critical reviews vol. 24,1 (2021): 30-50. doi: https://doi.org/10.1080/10937404.2020.1855279
Santos L, Oliveira C, Vasconcelos BM, Vilela D, Melo L, Ambrósio L, da Silva A, Murback L, Kurissio J, Cavalcante J, Cassaro CV, Barros L, Barraviera B, Ferreira RS. Good management practices of venomous snakes in captivity to produce biological venom-based medicines: achieving replicability and contributing to pharmaceutical industry. J Toxicol Environ Health B Crit Rev. 2021 Jan 02;24(1):30-50. doi: 10.1080/10937404.2020.1855279. Epub 2020 Dec 14. PMID: 33308037.
Copy Download .nbib Format: NLM
CEVAP journal towards a new phase.

The journal of venomous animals and toxins including tropical diseases

Barraviera B.
PMID: 23849430
J Venom Anim Toxins Incl Trop Dis. 2013 Feb 27;19(1):1. doi: 10.1186/1678-9199-19-1.

No abstract available.

Cite
Barraviera B. CEVAP journal towards a new phase. J Venom Anim Toxins Incl Trop Dis. 2013;19(1):1doi: 10.1186/1678-9199-19-1.
Barraviera, B. (2013). CEVAP journal towards a new phase. The journal of venomous animals and toxins including tropical diseases, 19(1), 1. https://doi.org/10.1186/1678-9199-19-1
Barraviera, Benedito. "CEVAP journal towards a new phase." The journal of venomous animals and toxins including tropical diseases vol. 19,1 (2013): 1. doi: https://doi.org/10.1186/1678-9199-19-1
Barraviera B. CEVAP journal towards a new phase. J Venom Anim Toxins Incl Trop Dis. 2013 Feb 27;19(1):1. doi: 10.1186/1678-9199-19-1. PMID: 23849430; PMCID: PMC3707102.
Copy Download .nbib Format: NLM
Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response.

The journal of venomous animals and toxins including tropical diseases

Pereira AV, de Barros G, Pinto EG, Tempone AG, Orsi Rde O, Dos Santos LD, Calvi S, Ferreira RS, Pimenta DC, Barraviera B.
PMID: 26752985
J Venom Anim Toxins Incl Trop Dis. 2016 Jan 08;22:1. doi: 10.1186/s40409-016-0055-x. eCollection 2016.

BACKGROUND: Apis mellifera venom, which has already been recommended as an alternative anti-inflammatory treatment, may be also considered an important source of candidate molecules for biotechnological and biomedical uses, such as the treatment of parasitic diseases.METHODS: Africanized honeybee venom...

Cite
Pereira AV, de Barros G, Pinto EG, et al. Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response. J Venom Anim Toxins Incl Trop Dis. 2016;22:1doi: 10.1186/s40409-016-0055-x.
Pereira, A. V., de Barros, G., Pinto, E. G., Tempone, A. G., Orsi, R. d. e. . O., Dos Santos, L. D., Calvi, S., Ferreira, R. S., Pimenta, D. C., & Barraviera, B. (2016). Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response. The journal of venomous animals and toxins including tropical diseases, 221. https://doi.org/10.1186/s40409-016-0055-x
Pereira, Andreia Vieira, et al. "Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response." The journal of venomous animals and toxins including tropical diseases vol. 22 (2016): 1. doi: https://doi.org/10.1186/s40409-016-0055-x
Pereira AV, de Barros G, Pinto EG, Tempone AG, Orsi Rde O, Dos Santos LD, Calvi S, Ferreira RS, Pimenta DC, Barraviera B. Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response. J Venom Anim Toxins Incl Trop Dis. 2016 Jan 08;22:1. doi: 10.1186/s40409-016-0055-x. eCollection 2016. PMID: 26752985; PMCID: PMC4706697.
Copy Download .nbib Format: NLM
The 6(th) international conference on envenomation by Snakebites and Scorpion Stings in Africa: a crucial step for the management of envenomation.

The journal of venomous animals and toxins including tropical diseases

Chippaux JP, Akaffou MH, Allali BK, Dosso M, Massougbodji A, Barraviera B.
PMID: 26985189
J Venom Anim Toxins Incl Trop Dis. 2016 Mar 16;22:11. doi: 10.1186/s40409-016-0062-y. eCollection 2016.

During the 6(th) International Conference on Envenomation by Snakebites and Scorpion Stings in Africa held in Abidjan, from 1 to 5 June 2015, the measures for the management of envenomation were discussed and new recommendations were adopted by the...

Cite
Chippaux JP, Akaffou MH, Allali BK, et al. The 6(th) international conference on envenomation by Snakebites and Scorpion Stings in Africa: a crucial step for the management of envenomation. J Venom Anim Toxins Incl Trop Dis. 2016;22:11doi: 10.1186/s40409-016-0062-y.
Chippaux, J. P., Akaffou, M. H., Allali, B. K., Dosso, M., Massougbodji, A., & Barraviera, B. (2016). The 6(th) international conference on envenomation by Snakebites and Scorpion Stings in Africa: a crucial step for the management of envenomation. The journal of venomous animals and toxins including tropical diseases, 2211. https://doi.org/10.1186/s40409-016-0062-y
Chippaux, Jean-Philippe, et al. "The 6(th) international conference on envenomation by Snakebites and Scorpion Stings in Africa: a crucial step for the management of envenomation." The journal of venomous animals and toxins including tropical diseases vol. 22 (2016): 11. doi: https://doi.org/10.1186/s40409-016-0062-y
Chippaux JP, Akaffou MH, Allali BK, Dosso M, Massougbodji A, Barraviera B. The 6(th) international conference on envenomation by Snakebites and Scorpion Stings in Africa: a crucial step for the management of envenomation. J Venom Anim Toxins Incl Trop Dis. 2016 Mar 16;22:11. doi: 10.1186/s40409-016-0062-y. eCollection 2016. PMID: 26985189; PMCID: PMC4793573.
Copy Download .nbib Format: NLM
Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair.

The journal of venomous animals and toxins including tropical diseases

Mozafari R, Kyrylenko S, Castro MV, Ferreira RS, Barraviera B, Oliveira ALR.
PMID: 29681920
J Venom Anim Toxins Incl Trop Dis. 2018 Apr 12;24:11. doi: 10.1186/s40409-018-0147-x. eCollection 2018.

BACKGROUND: Peripheral nerve injury is a worldwide clinical problem, and the preferred surgical method for treating it is the end-to-end neurorrhaphy. When it is not possible due to a large nerve gap, autologous nerve grafting is used. However, these...

Cite
Mozafari R, Kyrylenko S, Castro MV, et al. Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair. J Venom Anim Toxins Incl Trop Dis. 2018;24:11doi: 10.1186/s40409-018-0147-x.
Mozafari, R., Kyrylenko, S., Castro, M. V., Ferreira, R. S., Barraviera, B., & Oliveira, A. L. R. (2018). Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair. The journal of venomous animals and toxins including tropical diseases, 2411. https://doi.org/10.1186/s40409-018-0147-x
Mozafari, Roghayeh, et al. "Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair." The journal of venomous animals and toxins including tropical diseases vol. 24 (2018): 11. doi: https://doi.org/10.1186/s40409-018-0147-x
Mozafari R, Kyrylenko S, Castro MV, Ferreira RS, Barraviera B, Oliveira ALR. Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair. J Venom Anim Toxins Incl Trop Dis. 2018 Apr 12;24:11. doi: 10.1186/s40409-018-0147-x. eCollection 2018. PMID: 29681920; PMCID: PMC5897995.
Copy Download .nbib Format: NLM
Fibrin biopolymer as scaffold candidate to treat bone defects in rats.

The journal of venomous animals and toxins including tropical diseases

Cassaro CV, Justulin LA, de Lima PR, Golim MA, Biscola NP, de Castro MV, de Oliveira ALR, Doiche DP, Pereira EJ, Ferreira RS, Barraviera B.
PMID: 31723344
J Venom Anim Toxins Incl Trop Dis. 2019 Nov 04;25:e20190027. doi: 10.1590/1678-9199-JVATITD-2019-0027. eCollection 2019.

BACKGROUND: Bone tissue repair remains a challenge in tissue engineering. Currently, new materials are being applied and often integrated with live cells and biological scaffolds. The fibrin biopolymer (FBP) proposed in this study has hemostatic, sealant, adhesive, scaffolding and...

Cite
Cassaro CV, Justulin LA, de Lima PR, et al. Fibrin biopolymer as scaffold candidate to treat bone defects in rats. J Venom Anim Toxins Incl Trop Dis. 2019;25:e20190027doi: 10.1590/1678-9199-JVATITD-2019-0027.
Cassaro, C. V., Justulin, L. A., de Lima, P. R., Golim, M. A., Biscola, N. P., de Castro, M. V., de Oliveira, A. L. R., Doiche, D. P., Pereira, E. J., Ferreira, R. S., & Barraviera, B. (2019). Fibrin biopolymer as scaffold candidate to treat bone defects in rats. The journal of venomous animals and toxins including tropical diseases, 25e20190027. https://doi.org/10.1590/1678-9199-JVATITD-2019-0027
Cassaro, Claudia Vilalva, et al. "Fibrin biopolymer as scaffold candidate to treat bone defects in rats." The journal of venomous animals and toxins including tropical diseases vol. 25 (2019): e20190027. doi: https://doi.org/10.1590/1678-9199-JVATITD-2019-0027
Cassaro CV, Justulin LA, de Lima PR, Golim MA, Biscola NP, de Castro MV, de Oliveira ALR, Doiche DP, Pereira EJ, Ferreira RS, Barraviera B. Fibrin biopolymer as scaffold candidate to treat bone defects in rats. J Venom Anim Toxins Incl Trop Dis. 2019 Nov 04;25:e20190027. doi: 10.1590/1678-9199-JVATITD-2019-0027. eCollection 2019. PMID: 31723344; PMCID: PMC6830407.
Copy Download .nbib Format: NLM
Fibrin Biopolymer Incorporated with Antimicrobial Agents: A Proposal for Coating Denture Bases.

Materials (Basel, Switzerland)

Venante HS, Chappuis-Chocano AP, Marcillo-Toala OO, da Silva RA, da Costa RMB, Pordeus MD, Barraviera B, Ferreira Junior RS, Lara VS, Neppelenbroek KH, Honório HM, Porto VC.
PMID: 33810381
Materials (Basel). 2021 Mar 26;14(7). doi: 10.3390/ma14071618.

The characteristics of the denture base surface, in combination with the oral environment, promote the colonization and development of

Cite
Venante HS, Chappuis-Chocano AP, Marcillo-Toala OO, et al. Fibrin Biopolymer Incorporated with Antimicrobial Agents: A Proposal for Coating Denture Bases. Materials (Basel). 2021;14(7)doi: 10.3390/ma14071618.
Venante, H. S., Chappuis-Chocano, A. P., Marcillo-Toala, O. O., da Silva, R. A., da Costa, R. M. B., Pordeus, M. D., Barraviera, B., Ferreira Junior, R. S., Lara, V. S., Neppelenbroek, K. H., Honório, H. M., & Porto, V. C. (2021). Fibrin Biopolymer Incorporated with Antimicrobial Agents: A Proposal for Coating Denture Bases. Materials (Basel, Switzerland), 14(7), . https://doi.org/10.3390/ma14071618
Venante, Helena Sandrini, et al. "Fibrin Biopolymer Incorporated with Antimicrobial Agents: A Proposal for Coating Denture Bases." Materials (Basel, Switzerland) vol. 14,7 (2021). doi: https://doi.org/10.3390/ma14071618
Venante HS, Chappuis-Chocano AP, Marcillo-Toala OO, da Silva RA, da Costa RMB, Pordeus MD, Barraviera B, Ferreira Junior RS, Lara VS, Neppelenbroek KH, Honório HM, Porto VC. Fibrin Biopolymer Incorporated with Antimicrobial Agents: A Proposal for Coating Denture Bases. Materials (Basel). 2021 Mar 26;14(7). doi: 10.3390/ma14071618. PMID: 33810381; PMCID: PMC8037169.
Copy Download .nbib Format: NLM
[No title available]

The journal of venomous animals and toxins including tropical diseases

de Oliveira LA, Ferreira RS, Barraviera B, de Carvalho FCT, de Barros LC, Dos Santos LD, Pimenta DC.
PMID: 29209361
J Venom Anim Toxins Incl Trop Dis. 2017 Nov 28;23:46. doi: 10.1186/s40409-017-0136-5. eCollection 2017.

BACKGROUND: Classically, METHODS: The crude Cdt venom was separated by using RP-HPLC and the toxins were identified by mass spectrometry (MS). Crotapotin was purified, reduced and alkylated in order to separate the peptide chains that were further analyzed by...

Cite
de Oliveira LA, Ferreira RS, Barraviera B, et al. . J Venom Anim Toxins Incl Trop Dis. 2017;23:46doi: 10.1186/s40409-017-0136-5.
de Oliveira, L. A., Ferreira, R. S., Barraviera, B., de Carvalho, F. C. T., de Barros, L. C., Dos Santos, L. D., & Pimenta, D. C. (2017). . The journal of venomous animals and toxins including tropical diseases, 2346. https://doi.org/10.1186/s40409-017-0136-5
de Oliveira, Laudicéia Alves, et al. "." The journal of venomous animals and toxins including tropical diseases vol. 23 (2017): 46. doi: https://doi.org/10.1186/s40409-017-0136-5
de Oliveira LA, Ferreira RS, Barraviera B, de Carvalho FCT, de Barros LC, Dos Santos LD, Pimenta DC. . J Venom Anim Toxins Incl Trop Dis. 2017 Nov 28;23:46. doi: 10.1186/s40409-017-0136-5. eCollection 2017. PMID: 29209361; PMCID: PMC5704381.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries